These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1056 related articles for article (PubMed ID: 25903466)
1. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
2. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related]
3. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Wang F; Ying H; He B; Pan Y; Sun H; Wang S Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720 [TBL] [Abstract][Full Text] [Related]
4. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
5. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
6. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma. Meng FL; Wang W; Jia WD Med Oncol; 2014 Sep; 31(9):177. PubMed ID: 25129312 [TBL] [Abstract][Full Text] [Related]
8. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage. Sun Q; Li J; Jin B; Wang T; Gu J Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism. Cao C; Wang C Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720 [TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247 [TBL] [Abstract][Full Text] [Related]
12. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448 [TBL] [Abstract][Full Text] [Related]
13. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
14. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
17. [Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance]. Zhan MX; Li Y; Hu BS; Shao PJ; Meng QW; He X; Huang JW; Lu LG Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1830-2. PubMed ID: 24124720 [TBL] [Abstract][Full Text] [Related]
18. Decreased expression of serum miR-424 correlates with poor prognosis of patients with hepatocellular carcinoma. Yao H; Liu X; Chen S; Xia W; Chen X Int J Clin Exp Pathol; 2015; 8(11):14830-5. PubMed ID: 26823812 [TBL] [Abstract][Full Text] [Related]
19. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]